Holly Andersen is a Cardiology physician affiliated with NewYork–Presbyterian Hospital. OpenAlex indexes 9 publications with 433 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
125 E 72nd St
New York, NY 100214250
Telephone
212-628-6100Registry record last updated 14 Sept 2011.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- HEARTFLOW, INC.Program year20253 payments
- SCPHARMACEUTICALS INC.Program year20251 payment
- Novo Nordisk IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
64.1%Statin24.7%Rosuvastatin Calcium54%Atorvastatin Calcium35%Simvastatin8%Pravastatin Sodium3%Part D<11 patientsAngiotensin receptor blocker (ARB)13%Losartan Potassium75%Valsartan10%Losartan-Hydrochlorothiazide10%Olmesartan Medoxomil6%Part D<11 patients+ 9 more classes in this area
Nervous system
12.6%gamma-Aminobutyric Acid A Receptor Positive Modulator4.7%Zolpidem Tartrate100%Part D≥21 patientsSSRI3.6%Escitalopram Oxalate68%Citalopram Hbr16%Trazodone Hcl16%Part D<11 patients+ 3 more classes in this area
Blood & clotting
8.1%Factor Xa inhibitor6.8%Eliquis80%Xarelto21%Part D<11 patientsP2Y12 inhibitor1.3%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Knowledge, Attitudes, and Beliefs Regarding Cardiovascular Disease in Women
Journal of the American College of Cardiology
2017 - Evaluation of HeartSmarts, a Faith-Based Cardiovascular Health Education Program
Journal of Religion and Health
2016 - WOMEN SPEAK UP ABOUT HEART HEALTH ACTION: A WOMENS HEART ALLIANCE RESEARCH REPORT
Journal of the American College of Cardiology
2016 - Gender, Cardiovascular Disease, and the Sexism of Obesity ∗
Journal of the American College of Cardiology
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Kevin Clerkin, MD
NewYork–Presbyterian Hospital
Brandon Swed, MD
NewYork–Presbyterian Hospital
Lawrence Lenke, MD
NewYork–Presbyterian Hospital
Manuel Hidalgo Medina, MD
NewYork–Presbyterian Hospital
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”